YOLFTbeta
Eurofins-Cerep SA

Eurofins-Cerep SA

ALECR · PA · Healthcare / Diagnostics & Research

18,400.00EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close18,400.00
Open18,400.00
Day Range18,400.00 – 18,400.00
52-Week Range15,000.00 – 18,600.00
Volume0
Market Cap91.30M
P/E (TTM)11.75
Forward P/E74.07
EPS1,540.31
Dividend Yield0.00%
Beta0.02
50-Day Avg17,186.00
200-Day Avg16,636.00

About

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Damien Vielliard
  • Employees211
  • Headquarters2 rue du professeur GargouIl, Celle-Lévescault, France, 86600, France
  • Websitehttps://www.eurofins.fr/cerep

Leadership

  • Mr. Damien VielliardCEO & Director · b. 1977
  • Ms. Sophie MacaultGeneral Counsel & Corporate Secretary

Financials

Income Statement

Currency: EUR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue18.28M27.67M34.50M34.12M51.34M52.89M52.83M31.46M31.59M26.84M24.18M22.82M22.07M20.21M18.50M22.51M23.44M24.41M25.45M31.01M32.67M41.62M47.63M44.07M40.46M40.98M
Growth (%)-+51.32%+24.70%-1.11%+50.47%+3.01%-0.10%-40.45%+0.41%-15.04%-9.89%-5.66%-3.29%-8.40%-8.48%+21.70%+4.10%+4.15%+4.27%+21.82%+5.35%+27.40%+14.45%-7.47%-8.20%+1.28%
Cost of Revenue--13.79M17.11M20.78M23.18M19.56M11.39M11.72M11.10M10.44M8.38M8.22M11.27M10.85M4.79M11.88M11.59M12.94M16.53M16.83M20.79M24.01M23.86M23.00M34.19M
Gross Profit--20.71M17.01M30.57M29.70M33.27M20.07M19.87M15.74M13.74M14.43M13.85M8.94M7.65M17.72M11.56M12.82M12.52M14.48M15.84M20.83M23.62M20.21M17.45M6.79M
Gross Margin--60.03%49.85%59.53%56.17%62.97%63.78%62.90%58.65%56.82%63.25%62.76%44.23%41.33%78.70%49.32%52.53%49.18%46.68%48.49%50.04%49.59%45.85%43.14%16.56%
Operating Expense--0027.73M35.32M39.40M16.29M16.92M17.13M17.47M13.45M12.95M9.76M9.30M16.73M9.93M8.45M7.53M10.25M10.29M10.69M12.14M13.75M12.95M3.92M
Operating Income-2.01M20.71M17.01M2.83M-5.62M-6.13M3.78M2.95M-1.39M-3.72M984.00K900.00K-819.35K-1.66M986.47K1.63M4.37M4.98M4.23M5.54M10.13M11.48M6.46M4.50M2.87M
Operating Margin-7.26%60.03%49.85%5.52%-10.62%-11.61%12.01%9.35%-5.17%-15.39%4.31%4.08%-4.05%-8.96%4.38%6.96%17.91%19.58%13.63%16.97%24.35%24.09%14.66%11.13%6.99%
EBITDA--20.71M17.01M4.91M-2.36M4.90M5.72M4.92M508.00K-2.08M2.63M2.47M-521.85K-792.62K1.79M2.46M4.69M4.03M5.06M6.30M10.85M12.94M9.10M8.89M5.23M
EBITDA Margin--60.03%49.85%9.56%-4.45%9.28%18.19%15.58%1.89%-8.60%11.52%11.18%-2.58%-4.28%7.97%10.49%19.21%15.82%16.32%19.28%26.07%27.17%20.65%21.97%12.77%
Net Income235.00K2.40M3.20M461.00K2.76M-6.69M-16.94M9.16M-2.15M-2.17M-5.41M-79.00K317.00K-889.07K-494.83K1.81M2.49M3.85M3.86M4.37M5.58M9.84M11.52M7.64M7.15M4.78M
Net Income Margin1.29%8.66%9.26%1.35%5.38%-12.65%-32.06%29.12%-6.79%-8.08%-22.35%-0.35%1.44%-4.40%-2.67%8.03%10.61%15.77%15.16%14.09%17.07%23.65%24.20%17.33%17.68%11.67%
R&D-------5.74M6.78M5.66M4.33M2.67M2.95M3.57M2.98M2.67M3.10M3.17M3.59M3.61M3.76M3.70M4.30M4.47M-4.98M
R&D as % of Total Revenue-------18.26%21.45%21.09%17.92%11.70%13.36%17.68%16.11%11.86%13.23%12.99%14.10%11.64%11.51%8.89%9.03%10.14%-12.15%
Interest Expense001.48M1.53M496.00K652.00K1.00M755.00K627.00K542.00K316.00K257.00K209.00K31.40K13.24K136610050.88K16.01K34.46K3.17K7.83K09.83K
Interest Expense % of Total Revenue0.00%0.00%4.27%4.49%0.97%1.23%1.90%2.40%1.98%2.02%1.31%1.13%0.95%0.16%0.07%0.00%0.00%0.00%0.00%0.16%0.05%0.08%0.01%0.02%0.00%0.02%

Balance Sheet

Currency: EUR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets23.67M40.90M47.72M51.24M63.87M83.65M76.37M62.73M54.91M44.31M35.90M32.72M30.28M27.89M22.90M25.18M25.94M30.18M35.26M39.95M46.06M59.73M71.05M79.25M84.06M88.84M
Total Liabilities11.70M14.73M18.39M21.58M31.83M52.52M62.25M38.81M33.44M25.41M22.26M19.16M16.35M14.54M9.74M10.21M8.49M8.87M10.09M10.42M10.95M14.35M14.12M14.63M12.32M12.43M
Total Equity11.97M26.17M29.32M29.66M32.05M31.13M14.12M24.04M21.47M18.90M13.63M13.57M13.93M13.35M13.16M14.97M17.46M21.31M25.16M29.53M35.11M45.38M56.93M64.61M71.74M76.35M
Cash1.92M3.07M2.62M809.00K5.87M7.58M7.29M2.68M2.98M1.32M2.62M2.45M2.23M3.54M2.25M2.38M3.92M1.45M783.03K3.34M4.90M1.30M12.81M8.63M17.58M9.12M
Total Debt----9.79M22.21M23.75M13.80M11.09M7.58M5.28M4.55M3.50M2.31M87.18K117.98K-346.00K300.53K5.15K20.00K18.89K4.83K3.44K328.52K7.68K
Net Debt----3.92M14.63M16.45M11.12M8.11M6.26M2.66M2.10M1.27M-1.23M-2.16M-2.26M-3.92M-1.10M-482.50K-3.33M-4.88M-1.28M-12.81M-8.63M-17.25M-9.12M

Cash Flow

Currency: EUR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.48M4.30M3.62M9.38M1.89M-2.49M4.20M4.88M1.19M-1.10M3.52M1.13M1.03M-2.32M434.88K5.59M4.24M--------
Investing Cash Flow---3.27M-2.85M-11.57M-2.12M-3.71M-1.21M-1.49M-695.00K-807.00K-421.00K-561.00K-496.00K-1.14M-830.25K-3.93M-767.00K--------
Financing Cash Flow-13.05M418.00K-677.00K-1.77M-325.00K-2.54M2.61M-4.29M-3.90M-2.87M-1.18M-1.24M-1.00M-40.78K30.80K-117.98K-5.94M--------
Capital Expenditure1.82M4.20M2.09M2.64M2.86M2.58M1.49M1.31M1.58M797.00K812.00K571.00K647.00K593.00K1.22M952.21K5.67M1.06M00000000
Free Cash Flow--2.21M981.00K6.52M-694.00K-3.98M2.89M3.30M388.00K-1.91M2.95M484.00K433.00K-3.53M-517.33K-72.92K3.18M--------
FCF to OCF--51.44%27.11%69.47%-36.82%159.70%68.80%67.60%32.74%173.82%83.77%42.79%42.20%152.46%-118.96%-1.30%74.94%--------

Earnings

Report DateFeb 3, 2016Oct 26, 2016Mar 24, 2017May 2, 2017Oct 4, 2017Mar 23, 2018May 9, 2018Oct 18, 2018Mar 22, 2019May 29, 2019Aug 28, 2019Nov 12, 2019Mar 27, 2020Jun 3, 2020Sep 2, 2020Nov 10, 2020Mar 26, 2021Jun 2, 2021Sep 23, 2021Nov 16, 2021Apr 12, 2022Sep 22, 2022Nov 15, 2022Apr 13, 2023Sep 21, 2023Nov 14, 2023Apr 11, 2024Nov 18, 2024Apr 3, 2025Oct 2, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual300.99370.29122.51122.51449.64313.640.00416.34348.640.00209.360.00657.080.00516.850.00588.880.00900.280.001051.111092.390.000.000.000.000.000.000.000.00
Surprise------------------------------
Timing------------------------------

Key Statistics & Ratios

Market Cap91.30M
Enterprise Value70.26M
Trailing P/E11.75
Forward P/E74.07
PEG Ratio3.26
Price / Sales2.22
Price / Book1.19
EPS1,540.31
Revenue (TTM)41.10M
Gross Profit (TTM)22.04M
EBITDA5.73M
Profit Margin11.64%
Operating Margin10.17%
Return on Equity6.45%
Return on Assets2.43%
Shares Outstanding5.04K
Shares Float0
Beta0.02
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 27, 20171:50
  • Jan 5, 20151:50